O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
-9.96%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$6.16B
AUM Growth
+$6.16B
(-21%)
Cap. Flow
-$479M
Cap. Flow
% of AUM
-7.78%
Top 10 Holdings %
Top 10 Hldgs %
32.31%
Holding
169
New
10
Increased
33
Reduced
25
Closed
28
Top Buys
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$85.3M |
| 2 |
Pfizer
PFE
|
$66.8M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$60.6M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$54.6M |
| 5 |
argenx
ARGX
|
$53.5M |
Top Sells
| 1 |
Merck
MRK
|
$136M |
| 2 |
Bristol-Myers Squibb
BMY
|
$126M |
| 3 |
HCA Healthcare
HCA
|
$100M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
$80.7M |
| 5 |
SVA
Sinovac Biotech, Ltd
SVA
|
$72.7M |
Sector Composition
| 1 | Healthcare | 97.85% |
| 2 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWTX
1
DELISTED
SpringWorks Therapeutics
SWTX
| $340M | 5.52% | 6,028,307 | – | – |
|
|
HZNP
2
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $231M | 3.75% | 2,196,555 -303,500 | -12% | -$31.9M |
|
3
Boston Scientific
BSX
$156B
| $204M | 3.3% | 4,599,500 -952,800 | -17% | -$42.2M |
|
|
4
Pfizer
PFE
$141B
| $202M | 3.28% | 3,905,500 +1,290,100 | +49% | +$66.8M |
|
|
THRX
5
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $196M | 3.19% | 17,041,668 +203,000 | +1% | +$2.34M |
|
|
6
Bristol-Myers Squibb
BMY
$96B
| $190M | 3.09% | 2,607,700 -1,732,100 | -40% | -$126M |
|
7
Humana
HUM
$36.5B
| $166M | 2.69% | 381,700 +63,400 | +20% | +$27.6M |
|
8
Intuitive Surgical
ISRG
$170B
| $161M | 2.61% | 534,200 +160,400 | +43% | +$48.4M |
|
9
UnitedHealth
UNH
$281B
| $150M | 2.43% | 294,200 +23,200 | +9% | +$11.8M |
|
10
Adicet Bio
ACET
$59.9M
| $149M | 2.41% | 7,447,141 | – | – |
|
11
AbbVie
ABBV
$372B
| $148M | 2.41% | 915,600 -153,200 | -14% | -$24.8M |
|
12
PMV Pharmaceuticals
PMVP
$74.2M
| $143M | 2.31% | 6,855,423 -475,000 | -6% | -$9.89M |
|
13
Edgewise Therapeutics
EWTX
$1.51B
| $135M | 2.19% | 13,944,680 | – | – |
|
|
MRTX
14
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $134M | 2.17% | 1,630,500 +204,100 | +14% | +$16.8M |
|
|
15
BioMarin Pharmaceuticals
BMRN
$11.2B
| $127M | 2.06% | 1,647,030 +786,150 | +91% | +$60.6M |
|
16
Edwards Lifesciences
EW
$47.8B
| $124M | 2.01% | 1,051,300 -24,900 | -2% | -$2.93M |
|
17
Stryker
SYK
$150B
| $122M | 1.98% | 457,100 -8,200 | -2% | -$2.19M |
|
18
Arcutis Biotherapeutics
ARQT
$1.86B
| $117M | 1.9% | 6,073,850 | – | – |
|
19
Iovance Biotherapeutics
IOVA
$807M
| $110M | 1.79% | 6,633,006 +295,306 | +5% | +$4.92M |
|
20
Vertex Pharmaceuticals
VRTX
$100B
| $104M | 1.69% | 400,200 -257,900 | -39% | -$67.3M |
|
|
SGEN
21
DELISTED
Seagen Inc. Common Stock
SGEN
| $96.2M | 1.56% | 667,700 +12,100 | +2% | +$1.74M |
|
22
Keros Therapeutics
KROS
$618M
| $91.3M | 1.48% | 1,679,417 | – | – |
|
23
Guardant Health
GH
$8.41B
| $87.8M | 1.42% | 1,325,400 +98,000 | +8% | +$6.49M |
|
|
BHVN
24
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $85.3M | 1.38% | +719,034 | New | +$85.3M |
|
|
TCDA
25
DELISTED
Tricida, Inc. Common Stock
TCDA
| $84.5M | 1.37% | 10,280,947 | – | – |
|